Stock screener

IMMX

Conviction 93HealthcareScan · Thu, Jun 25, 2026
IMMX$9.74-3.04%
ResistanceSupportVol 14
63 bars
Vol MA14 2.14M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Immix Biopharma, Inc.PHARMACEUTICAL PREPARATIONSwww.immixbio.com
Price9.74
Change-3.04%
Gap-0.75%
Rel volume3.06×
Avg volume1.85M
Avg $ vol16.47M
SMA 208.75
SMA 509.24
SMA 2006.45
Price vs 50+5.39%
Price vs 200+50.99%
MA stackbullish
50/200 cross
Supertrenddown · 10.13
RSI (14)59
MACD hist0.21
MACD crossbull · 7d
Stoch %K / %D73 / 82
ADX (14)24
+DI / −DI27 / 8
RSI divergence
MACD divergenceBullish
ATR %+7.97%
ADR %8.27%
52w high11.12
52w low1.96
From 52w high-12.46%
Above 52w low+396.68%
New 52w highNo
SqueezeOff
Bollinger width29.10%
%B0.89
Donchian pos73.16%
Donchian high10.50
Donchian low7.65
AVWAP (52w high)9.17
vs AVWAP high+6.19%
AVWAP (52w low)7.12
vs AVWAP low+36.78%
OBV trendFlat
Chaikin MF (20)-0.28
Today vs 20d3.06×
Avg vol (14d)2.14M
Avg vol (20d)1.85M
Avg $ vol (20d)16.47M
Market cap529.7M
RS 3m (vs SPY)+4.90%
RS 6m (vs SPY)+67.79%
RS line new highNo
Trend template8/8
Technical rank89.7
1 week+6.63%
1 month+10.12%
3 months+9.26%
6 months+67.56%
1 year+334.60%
YTD+79.28%
P/E-17.99
P/B6.28
P/S26.48
P/FCF-21.48
EPS-0.8900
Div yield
ROE-34.89%
ROA-30.72%
Debt/Eq
Current8.76
EV/EBITDA
Gross margin
Net margin-147.19%
Rev growth
EPS growth-36.21%
Price target20.20
Target upside107.50%
Analyst ratingBuy
Institutional39.63%
Ent. value450.45M
Revenue20M
Net income-10.09M
Gross profit
Free cash flow-24.66M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out54.41M
Employees21
ListedThu, Dec 16, 2021
Free float31.78M
Float %60.0%
Short interest4.03M
Days to cover2.0d
Short volume69.4%
Squeeze score70 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.18 vs −$0.21
Last surprise+14.3% beat
Setup gradeA+
Conviction93 / 100
Pattern quality
Tech rank89.7 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance10.58
Support7.83
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IMMX

All disclosures →
No recent disclosed trades by Congress in IMMX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IMMX · 7 buys

InsiderSideShares
Adams Helen C.
Director · Common Stock · 2026-05-22
Grant6.25K
Chudnovsky Yekaterina
Director · Common Stock · 2026-05-22
Grant6.25K
Ng Carey
Director · Common Stock · 2026-05-22
Other
Hsu Jason
Director · Stock Option (Right to Buy) · 2026-05-22
Grant12.5K
Marquet Magda
Director · Stock Option (Right to Buy) · 2026-05-22
Grant12.5K
BUCHAN JANE
Director · Stock Option (Right to Buy) · 2026-05-22
Grant12.5K
CHANG NANCY T
Director · Common Stock · 2026-05-22
Other
Hsu Jason
Director · Common Stock · 2026-05-22
Other
Hsu Jason
Director · Common Stock · 2026-05-22
Grant6.25K
Rachman Ilya M
CEO and Chairman · Stock Option (Right to Buy) · 2026-05-22
Grant500K

SEC filings

EDGAR filings in IMMX · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.